Berger Montague

Recent News

• FIRST HIGH-SCHOOL EDUCATION GROUP CO., LTD. Company News: Berger Montague Investigates Securities Fraud Allegations Against First High-School Education Group Co., Ltd. (FHS); Lead Plaintiff Deadline is July 11, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 5, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the American Depositary Shares ("ADSs") of First High-School Education Group Co., Ltd. (NYSE: FHS) ("FHS" or the "Company") on or traceable to the Company's March 2021 initial public offering (the "Class Period"). If you purchased the ADSs of FHS during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests,...

  2022-07-05 4:33 PM EDT
• VERRICA PHARMACEUTICALS, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (VRCA); Lead Plaintiff Deadline is August 5, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 5, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Verrica Pharmaceuticals, Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) between May 28, 2021 and May 24, 2022 (the "Class Period"). If you purchased the securities of Verrica during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or...

  2022-07-05 12:53 PM EDT
• UNILEVER PLC Company News: Berger Montague Investigates Securities Fraud Allegations Against Unilever PLC (UL); Lead Plaintiff Deadline is August 15, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 5, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Unilever PLC ("Unilever" or the "Company") (NYSE: UL) between September 2, 2020 and July 21, 2021 (the "Class Period"). If you purchased the securities of Unilever during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Michael...

  2022-07-05 12:51 PM EDT
• APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (APYX); Lead Plaintiff Deadline is August 5, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 5, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX) between May 12, 2021 and March 11, 2022 (the "Class Period"). If you purchased the securities of Apyx during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or...

  2022-07-05 12:49 PM EDT
• VERRICA PHARMACEUTICALS, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (VRCA); Lead Plaintiff Deadline is August 5, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 1, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Verrica Pharmaceuticals, Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) between May 28, 2021 and May 24, 2022 (the "Class Period"). If you purchased the securities of Verrica during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or...

  2022-07-01 10:39 AM EDT
• UNILEVER PLC Company News: Berger Montague Investigates Securities Fraud Allegations Against Unilever PLC (UL); Lead Plaintiff Deadline is August 15, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 1, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Unilever PLC ("Unilever" or the "Company") (NYSE: UL) between September 2, 2020 and July 21, 2021 (the "Class Period"). If you purchased the securities of Unilever during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Michael...

  2022-07-01 10:32 AM EDT
• APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (APYX); Lead Plaintiff Deadline is August 5, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - July 1, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX) between May 12, 2021 and March 11, 2022 (the "Class Period"). If you purchased the securities of Apyx during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or...

  2022-07-01 10:24 AM EDT
• DENTSPLY SIRONA, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Dentsply Sirona, Inc. (XRAY); Lead Plaintiff Deadline is August 1, 2022

  Philadelphia, Pennsylvania--(Newsfile Corp. - June 21, 2022) - Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022 (the "Class Period"). If you purchased the securities of Dentsply during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or...

  2022-06-21 3:31 PM EDT